HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 80.64 EUR -1.9%

Market Cap: €5.5B

C	Corcept Therapeutics Inc SWB:HTD	US
A	Ardelyx Inc F:41X	US
C	Comcast Corp F:CTP2	US
	Metal Powder Works Ltd ASX:MPW	AU
T	Tokyo Electron Ltd F:TKY0	JP
C	China Citic Bank Corp Ltd XMUN:D7C	CN
	Volvo AB OTC:VLVLY	SE
W	WEX Inc F:WL9	US
P	Paccar Inc XMUN:PAE	US
I	Imperial Brands PLC XBER:ITB	UK
	Engie SA OTC:ENGIY	FR
	Stride Inc F:0AJ	US
	Valneva SE NASDAQ:VALN	FR

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Low Operating Margin

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

23% > 1%

Low Net Margin

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

22% > 7%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

23%

Declining Free Cash Flow Margin

31% > 13%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

31%

Declining ROIC

63% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.